<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">784799</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2021.784799</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Sulphenylation of CypD at Cysteine 104: A Novel Mechanism by Which SO<sub>2</sub> Inhibits Cardiomyocyte Apoptosis</article-title>
<alt-title alt-title-type="left-running-head">Lv et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">SO<sub>2</sub>-Sulphenylated CypD and Apoptosis</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lv</surname>
<given-names>Boyang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1496119/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Hanlin</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1108920/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qiu</surname>
<given-names>Bingquan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Lulu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/528754/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ge</surname>
<given-names>Mei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/910920/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bu</surname>
<given-names>Dingfang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/400359/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Kun</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/555157/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yu</surname>
<given-names>Xiaoqi</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/288269/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Du</surname>
<given-names>Jiantong</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/454766/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Liu</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1576639/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Chaoshu</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/19136/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Yaqian</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/421451/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Du</surname>
<given-names>Junbao</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/40308/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Jin</surname>
<given-names>Hongfang</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/400195/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Pediatrics, Peking University First Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Department of Ophthalmology, Peking University First Hospital</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Key Laboratory of Molecular Cardiology, Ministry of Education</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<sup>5</sup>
<institution>Department of Physiology and Pathophysiology, Peking University Health Science Centre</institution>, <addr-line>Beijing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/946394/overview">Zhi Qi</ext-link>, Nankai University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/626400/overview">Jie Tian</ext-link>, Children&#x2019;s Hospital of Chongqing Medical University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/48581/overview">Zhi-Ren Zhang</ext-link>, Harbin Medical University, China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yaqian Huang, <email>yaqianhuang@126.com</email>; Junbao Du, <email>junbaodu1@126.com</email>; Hongfang Jin, <email>jinhongfang51@126.com</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>01</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>784799</elocation-id>
<history>
<date date-type="received">
<day>28</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>12</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Lv, Peng, Qiu, Zhang, Ge, Bu, Li, Yu, Du, Yang, Tang, Huang, Du and Jin.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Lv, Peng, Qiu, Zhang, Ge, Bu, Li, Yu, Du, Yang, Tang, Huang, Du and Jin</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>
<bold>Objectives:</bold> The study was designed to explore the role of endogenous gaseous signaling molecule sulfur dioxide (SO<sub>2</sub>) in the control of cardiomyocyte apoptosis and its molecular mechanisms.</p>
<p>
<bold>Methods:</bold> Neonatal mouse cardiac myocytes (NMCMs) and H9c2 cells were used in the cell experiments. The endogenous SO<sub>2</sub> pathway including SO<sub>2</sub> level and the expression of SO<sub>2</sub>-generating enzyme aspartate aminotransferase 1/2 (AAT1/2) were detected in NMCMs. The apoptosis of cardiomyocytes was examined by a TUNEL assay. The cleavage and the activity of apoptotic proteins caspase9 and caspase3 were measured. The content of ATP, the opening of mitochondrial permeability transition pore (mPTP), and the cytochrome c (cytc) leakage were detected by immunofluorescence. The sulphenylation of cyclophilin-D (CypD) was detected by biotin switch analysis. The four CypD mutant plasmids in which cysteine sites were mutated to serine were constructed to identify the SO<sub>2</sub>-affected site <italic>in&#x20;vitro</italic>.</p>
<p>
<bold>Results:</bold> ISO down-regulated the endogenous SO<sub>2</sub>/AAT pathway of cardiomyocytes in association with a significant increase in cardiomyocyte apoptosis, demonstrated by the increases in apoptosis, cleaved-caspase3/caspase3 ratio, and caspase3 activity. Furthermore, ISO significantly reduced ATP production in H9c2 cells, but the supplement of SO<sub>2</sub> significantly restored the content of ATP. ISO stimulated mPTP opening, resulting in an increase in the release of cytc, which further increased the ratio of cleaved caspase9/caspase9 and enhanced the protein activity of caspase9. While, the supplementation of SO<sub>2</sub> reversed the above effects. Mechanistically, SO<sub>2</sub> did not affect CypD protein expression, but sulphenylated CypD and inhibited mPTP opening, resulting in an inhibition of cardiomyocyte apoptosis. The C104S mutation in CypD abolished SO<sub>2</sub>-induced sulphenylation of CypD, and thereby blocked the inhibitory effect of SO<sub>2</sub> on the mPTP opening and cardiomyocyte apoptosis.</p>
<p>
<bold>Conclusion:</bold> Endogenous SO<sub>2</sub> sulphenylated CypD at Cys104 to inhibit mPTP opening, and thus protected against cardiomyocyte apoptosis.</p>
</abstract>
<kwd-group>
<kwd>sulfur dioxide</kwd>
<kwd>cardiomyocyte</kwd>
<kwd>apoptosis</kwd>
<kwd>sulphenylation</kwd>
<kwd>CypD</kwd>
</kwd-group>
<contract-num rid="cn001">81770422 82070445&#x20;81921001 81900872</contract-num>
<contract-num rid="cn002">7191012</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Beijing Municipality<named-content content-type="fundref-id">10.13039/501100004826</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>1 Introduction</title>
<p>Myocardial injury is an important pathophysiological process in a variety of cardiovascular diseases (<xref ref-type="bibr" rid="B23">Jin et&#x20;al., 2013</xref>), including hypertension, heart failure, and coronary heart disease (<xref ref-type="bibr" rid="B29">Leong et&#x20;al., 2017</xref>). Cardiomyocyte apoptosis plays a crucial part in cardiovascular diseases (<xref ref-type="bibr" rid="B37">Singh et&#x20;al., 2011</xref>). Therefore, clarifying the mechanisms underlying cardiomyocyte apoptosis in cardiovascular diseases has always been the focus of the research (<xref ref-type="bibr" rid="B1">Abbate and Narula, 2012</xref>). However, the exact mechanisms for cardiomyocyte apoptosis have not yet been fully clarified.</p>
<p>Sulfur dioxide (SO<sub>2</sub>) had been regarded as a waste gas in air pollution. Recent literature has shown that cardiovascular tissues can produce SO<sub>2</sub> endogenously (<xref ref-type="bibr" rid="B13">Du et&#x20;al., 2008a</xref>). Increasing evidences have confirmed that the endogenous SO<sub>2</sub> exerts crucial cardiovascular pathophysiologic functions (<xref ref-type="bibr" rid="B51">Zhou et&#x20;al., 2020</xref>). Our previous animal study showed that the down-regulated endogenous SO<sub>2</sub>/AAT pathway might be involved in the mechanisms underlying isoproterenol (ISO)- induced myocardial damage, and the protective role of SO<sub>2</sub> might be related to the enhancement of myocardial antioxidant capacity in rats (<xref ref-type="bibr" rid="B30">Liang et&#x20;al., 2011</xref>). In addition, <xref ref-type="bibr" rid="B23">Jin et&#x20;al. (2013)</xref> found that myocardial injury is related to the inhibition of the bcl2/cytc/caspase9/caspase3 pathway mediated by SO<sub>2</sub>. However, the molecular mechanisms by which endogenous SO<sub>2</sub> protected cardiomyocyte injury and apoptosis are completely not&#x20;clear.</p>
<p>Mitochondrial permeability transition refers to the process that the inner membrane of mitochondria allows solutes up to 1.5&#xa0;kDa to pass freely (<xref ref-type="bibr" rid="B27">Kwong and Molkentin, 2015</xref>). Prolonged opening of mitochondrial permeability transition pore (mPTP) can lead to mitochondrial energy dysfunction, swelling, rupture, apoptosis, and necrotic cell death (<xref ref-type="bibr" rid="B50">Zhou et&#x20;al., 2019</xref>). Cyclophilin-D (CypD) locates in the mitochondrial matrix and is a peptidyl-prolyl isomerase. CypD translocates from mitochondrial matrix to mitochondrial inner membrane and binds to adenine nucleotide translocator (ANT) to initiate the formation of mPTP complex. Therefore, CypD acts as an important regulator of switching the mPTP opening (<xref ref-type="bibr" rid="B40">Sun et&#x20;al., 2019</xref>). It has been reported that a variety of post-translational modifications occur in CypD (<xref ref-type="bibr" rid="B15">Elrod and Molkentin, 2013</xref>), such as S-nitrosylation (<xref ref-type="bibr" rid="B34">Nguyen et&#x20;al., 2011</xref>), acetylation (<xref ref-type="bibr" rid="B4">Amanakis et&#x20;al., 2021</xref>), and phosphorylation (<xref ref-type="bibr" rid="B20">Hurst et&#x20;al., 2020</xref>). As a small gaseous signaling molecule, SO<sub>2</sub> regulates downstream proteins and exerts biological effects through post-translational sulphenylation. As a reversible form of post-translational modification, sulphenylation can oxidize cysteine mercaptan to sulphenic acid (Cys-SOH) and regulate protein function (<xref ref-type="bibr" rid="B39">Song et&#x20;al., 2020</xref>). According to the amino acid sequence analysis of the CypD, the human CypD protein contains four cysteines. However, it is not clear whether endogenous SO<sub>2</sub> can inhibit the opening of mPTP to reduce cardiomyocyte apoptosis through the sulphenylation of&#x20;CypD.</p>
<p>Therefore, in this study, the role of the endogenous SO<sub>2</sub> in the development of ISO-induced cardiomyocyte apoptosis was investigated. Moreover, we explored its mechanism from a new point of view that SO<sub>2</sub> likely inhibits the opening of mPTP by chemically modifying CypD, thus alleviating cardiomyocyte apoptosis.</p>
</sec>
<sec id="s2">
<title>2 Materials and Methods</title>
<sec id="s2-1">
<title>2.1 Reagent</title>
<p>Sodium hydrogen sulfite and sodium sulfite (NaHSO<sub>3</sub>/Na<sub>2</sub>SO<sub>3</sub>, freshly mixed at 1:3&#xa0;M ratio, pH 7.4) were used as SO<sub>2</sub> donors and purchased from Sigma (<xref ref-type="bibr" rid="B48">Zhang et&#x20;al., 2021</xref>). Isoprenaline hydrochloride was purchased from Sigma (I5627). A chemically selective fluorescent probe SS-1 was provided by Professor Kun Li and Xiaoqi Yu. DAz-2 was used as a protein sulphenylation probe (13382, Cayman, Michigan, USA) to capture and enrich the sulphenylated protein. The primary antibodies in the present study included CypD (abcam, USA), AAT1 (Sigma, USA), AAT2 (Sigma, USA), &#x3b2;-actin (Zsbio, China), caspase9 (CST, USA), caspase3 (Beyotime, China), cleaved caspase3 (Beyotime, China), cytc (santa, USA), His (Zsbio, China), and &#x3b2;-tubulin (Zsbio, China). Human CypD wild type (WT), and C104S, C82S, C157S, and C203S mutant plasmids were constructed by Sangon Biotech. The information of three kinds of ATP plasmids used in this study are as follows: EcAT3.10 (<xref ref-type="bibr" rid="B8">Conley et&#x20;al., 2017</xref>) was deposited at Addgene by Mathew Tantama (Addgene plasmid &#x23;107215); pm-iATPSnFR1.1 (<xref ref-type="bibr" rid="B32">Lobas et&#x20;al., 2019</xref>) (Addgene plasmid &#x23;102549) and cyto-iATPSnFR1.0 (<xref ref-type="bibr" rid="B32">Lobas et&#x20;al., 2019</xref>) (Addgene plasmid &#x23;102550) were deposited at Addgene by Baljit Khakh.</p>
</sec>
<sec id="s2-2">
<title>2.2 Cell Culture and Treatment</title>
<p>Culture of NMCMs: The kit for isolation of primary mouse cardiomyocytes was purchased from Thermo Fisher (Waltham, USA). In brief, the ventricular tissue parts from 1&#x2013;2&#xa0;days old C57BL/6J mouse neonates were subjected to modified enzymatic digestion. The enriched cardiomyocytes were cultured in DMEM with 1% penicillin-streptomycin solution (PS) and 10% fetal bovine serum (FBS). A cardiomyocyte growth supplement was added to inhibit the growth of the remaining fibroblasts.</p>
<p>NMCMs were divided randomly into control, ISO, ISO &#x2b; SO<sub>2</sub>, and SO<sub>2</sub> groups. For the control group, the cells were treated with the equivalent amount of saline for 48&#xa0;h. For the ISO group, they were treated with 10&#xa0;&#x3bc;mol/L ISO for 48&#xa0;h. For the ISO &#x2b; SO<sub>2</sub> group, the cells were given 100&#xa0;&#x3bc;mol/L SO<sub>2</sub> donor for 30&#x20;min and 10&#xa0;&#x3bc;mol/L ISO for 48&#xa0;h (<xref ref-type="bibr" rid="B11">Ding et&#x20;al., 2005</xref>). For the SO<sub>2</sub> group, cells were treated with 100&#xa0;&#x3bc;mol/L SO<sub>2</sub> donor for 0.5&#xa0;h and the equivalent amount of saline for 48&#xa0;h.</p>
<p>H9c2 cell culture: H9c2 rat embryonic cardiomyocytes were purchased from the National Infrastructure of Cell Line Resource (China) and they were cultured in DMEM medium containing 10% FBS, 1% PS, and 1% glutathione in 5% CO<sub>2</sub> at 37&#xb0;C. After a 6&#xa0;h of synchronous treatment in serum-free medium, the cell treatment and grouping were similar to those in NMCMs, except that in H9c2 cells the ISO treatment was 200&#xa0;&#x3bc;mol/L for 24&#xa0;h (<xref ref-type="bibr" rid="B10">Deng et&#x20;al., 2017</xref>).</p>
</sec>
<sec id="s2-3">
<title>2.3&#x20;<italic>In situ</italic> Fluorescent Imaging of SO<sub>2</sub>
</title>
<p>SS-1 is a chemically selective fluorescent probe for <italic>in situ</italic> visualization of SO<sub>2</sub>, developed and presented by Kun Li from Sichuan University, Sichuan, China (<xref ref-type="bibr" rid="B45">Yang et&#x20;al., 2017</xref>). As mentioned in the previous study, SO<sub>2</sub> in NMCMs was tested with an SS-1 probe (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2021a</xref>). The cells were incubated with a 10&#xa0;&#x3bc;M probe for 30&#xa0;min at 37&#xb0;C and then they were washed with PBS for removing the unlabeled probe. Subsequently, the cells were fixed with 4% paraformaldehyde solution. Finally, DAPI was added to stain nuclei. The green fluorescence detected by Olympus confocal laser scanning microscope (CK40, Olympus, Japan) is considered to be a positive signal.</p>
</sec>
<sec id="s2-4">
<title>2.4 AAT Activity Detected by Colorimetric Assay</title>
<p>AAT assay kit (Njjcbio, Nanjing, China) was used as described previously (<xref ref-type="bibr" rid="B48">Zhang et&#x20;al., 2021</xref>). Firstly, cells were collected and lysed on ice with pre-cooled PBS for 30&#xa0;min. The substrate solution and tested samples were added into the 96-well plate, and reacted at 37&#xb0;C for 30&#xa0;min. Then, 2,4-dinitrophenylhydrazine was added to each well, and the plate was placed at 37&#xb0;C for 20&#xa0;min. Finally, sodium hydroxide solution (200&#xa0;&#x3bc;l, 0.4&#xa0;mol/L) was added and gently mixed into each well. The plate was incubated at room temperature for 15&#xa0;min. Finally, the optical density was measured at the absorption wavelength of 510&#xa0;nm.</p>
</sec>
<sec id="s2-5">
<title>2.5&#x20;<italic>In situ</italic> Detection of Apoptosis in NMCMs and H9c2 Cells by TdT-Mediated dUTP Nick End Labeling Assay</title>
<p>
<italic>In situ</italic> cell death detection kit (Roche, Mannheim, Germany) was used as described previously (<xref ref-type="bibr" rid="B12">Du et&#x20;al., 2018</xref>). Firstly, after gently rinsed with PBS, the cells were fixed in 4% paraformaldehyde for 1&#xa0;h. Subsequently, they were permeabilized in 0.3% triton-X100 solution for 2&#xa0;min. They were incubated with the TUNEL reaction mixture for 60&#xa0;min at 37&#xb0;C, preventing from light after washing with PBS. Finally, the nuclei were stained by a DAPI dye. The fluorescence images were captured with the help of a confocal laser scanning microscope (CK40, Olympus, Japan). The cell apoptosis was measured by using the percentage of TUNEL positive cells to the total DAPI positive cells (<xref ref-type="bibr" rid="B12">Du et&#x20;al., 2018</xref>).</p>
</sec>
<sec id="s2-6">
<title>2.6 ATP Fluorescence Intensity of Cytoplasm and Cell Surface Monitored by Immunofluorescence Method in H9c2 Cells</title>
<p>H9c2 cells were seeded and grown to 50% confluency, and then pmiATPSnFR1.1 and cyto-iATPSnFR1.0 were respectively transfected into H9c2 cells, which were replaced with a complete culture medium after a 6&#xa0;h-transfection. The cells were imaged under a confocal laser scanning microscope (TCS SP8, Leica, Wetzlar, Germany) by the excitation at 473&#xa0;nm and the emission at 525&#xa0;nm.</p>
</sec>
<sec id="s2-7">
<title>2.7 ATP Fluorescence Intensity of Extracellular Matrix Monitored by Immunofluorescence Method in H9c2 Cells</title>
<p>The plasmid ecAT3.10 was transfected into 50% confluent H9c2 cells with a lipofectamine 3000 transfection reagent (Invitrogen, Carlsbad, CA, United&#x20;States). After a 6&#x20;h-transfection, the freshly completed culture medium was replaced. The activity of the ecATeam sensor was measured by examining the fluorescence intensities in CFP, CFP-YFPFRET, and YFP channels as described in the previous study. The settings of the bandpass filter were identical to those previously reported (<xref ref-type="bibr" rid="B8">Conley et&#x20;al., 2017</xref>). The ratio of CFP-YFPFRET to YFP is expressed as the activity of the ecATeam biosensor. The conformational change of the probe induced by ATP binding to the ecATeam probe increases the F&#xf6;rster resonance energy transfer (FRET) between the CFP donor and the YFP receptor (<xref ref-type="bibr" rid="B22">Imamura et&#x20;al., 2009</xref>). Therefore, the higher the ratio of CFP-YFPFRET to CFP, the more extracellular ATP binding, which indirectly reflects the extracellular ATP content.</p>
</sec>
<sec id="s2-8">
<title>2.8 Detection of Enzymatic Activities of Caspase3 and Caspase9 in H9c2 Cells</title>
<p>The enzymatic activities of caspase3 and caspase9 in H9c2 cells were detected with the commercial caspase3 and caspase9 activity kit, respectively (Applygen, Beijing, China) (<xref ref-type="bibr" rid="B42">Wang X. et&#x20;al., 2019</xref>). Briefly, with the lysis buffer, the cells were lysed for 30&#xa0;min at 4&#xb0;C, and then centrifuged at 12,000&#xa0;g for 5&#xa0;min to harvest the supernatant. The concentration of protein was measured by the Bradford method. Then, 50&#xa0;&#x3bc;g of cell lysate mixed with a reaction reagent was added to each well in a 96-well plate in order and then incubated for a period of 2&#xa0;h at 37&#xb0;C away from light. The activity of caspase3 or caspase9 was calculated from the absorbance value at 405&#xa0;nm.</p>
</sec>
<sec id="s2-9">
<title>2.9 Detection of the mPTP Opening in NMCMs and H9c2 Cells</title>
<p>The mPTP opening was detected using the mPTP detection kit (Genmed, Shanghai, China) according to the instruction of the manufacture. The detection principle is that the fluorescence of calcein-AM is quenched when it leaks from mitochondria via the opening mPTP. Therefore, the strong green fluorescence represents the closed mPTP while the faint green fluorescence represents the opening mPTP. After completing the cell experiment, the cells were rinsed and incubated with the staining working solution for 20&#xa0;min at 37&#xb0;C in the dark. The remaining staining solution was removed by twice rinse with the cleaning solution. After the fixation with 4% paraformaldehyde, the fluorescence was observed by using a laser confocal microscopy (CK40, Olympus, Japan) with 488&#xa0;nm excitation (Ex) and 505&#xa0;nm emission (Em) settings (<xref ref-type="bibr" rid="B38">Song et&#x20;al., 2018</xref>).</p>
</sec>
<sec id="s2-10">
<title>2.10 Detection of the Leakage of Mitochondrial Cytc in NMCMs</title>
<p>To determine the cytc subcellular localization, NMCMs were firstly incubated with the pre-warmed medium which contained 200&#xa0;nmol/L MitoTracker (Life Technologies, USA) for 1&#xa0;h. After the fixation with 4% paraformaldehyde, the cells were permeabilized in 0.1% Triton-X100 solution for 30&#xa0;min, and then the cells were incubated with the cytc primary antibody at 4&#xb0;C overnight. After the triplicate rinses with PBS buffer, an Alexa 594-conjugated secondary antibody (Life Technologies, USA) was added and then incubated for 90&#xa0;min at 37&#xb0;C in a dark container. Finally, images were captured with laser confocal microscopy (SP8-STED, Leica, Germany) (<xref ref-type="bibr" rid="B43">Wang X. et&#x20;al., 2019</xref>).</p>
</sec>
<sec id="s2-11">
<title>2.11 CypD Sulphenylation Detection by Biotin Switch Analysis</title>
<p>Sulphenylation of CypD in the H9c2 cells and purified CypD protein was detected by the BSA method as previously reported (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2021a</xref>). The H9c2 cells were lysed in a non-denaturing lysis buffer (Applygen, Beijing, China) containing 5&#xa0;mM DAz-2 for 20&#xa0;min. The supernatant was collected by centrifuging at 16,000&#xa0;g for 4&#xa0;min at 4&#xb0;C and gently shaken for 2.5&#xa0;h at 37&#xb0;C to label the DAZ-2. The DAz-2-labelled samples reacted with 250&#xa0;&#x3bc;M p-biotin in a water bath for 2&#xa0;h at 37&#xb0;C. Then, the hyperlinked Neutral Affinity Protein&#x2122; was added at a volume ratio of 1&#x2013;10 (Thermo Fisher Science) and incubated in a shaker for 4&#xa0;h to capture the sulfenylated protein at 4&#xb0;C. The sulphenylated proteins were mixed with a non-denaturing sample buffer and boiled for 10&#xa0;min. Then, the supernatant was collected by centrifuging at 5,000&#xa0;g for 10&#xa0;min and it was subjected to western blot for the sulphenylation of&#x20;CypD.</p>
<p>The human purified CypD protein (Abnova) was randomly divided into 3 groups: control, SO<sub>2</sub>, and SO<sub>2</sub>&#x2b;DTT groups. The amount of purified protein used in each group was 0.1&#xa0;&#x3bc;g. The protein was incubated for 2&#xa0;h at 37&#xb0;C. After the termination of the incubation experiment, the purified protein was divided into two portions to detect the sulphenylation of CypD and total CypD, respectively. The CypD sulphenylation was detected according to the abovementioned protocol in the cell experiment.</p>
</sec>
<sec id="s2-12">
<title>2.12&#x20;<italic>In situ</italic> Detection of CypD Sulphenylation in H9c2 Cells</title>
<p>A sulphenylated protein cell-based detection kit (Cayman, USA) with a DAz-2-based fluorescence probe was used to visualize the sulphenylated proteins in cells (<xref ref-type="bibr" rid="B39">Song et&#x20;al., 2020</xref>). The cells were treated with 100&#xa0;&#x3bc;M SO<sub>2</sub> for 1&#xa0;h or SO<sub>2</sub> plus 200&#xa0;&#x3bc;M DTT for 15&#xa0;min. The sulphenylation of CypD in H9c2 cells was observed by the co-localization of the fluorescent signals indicating CypD and sulphenylated proteins. Nuclei were stained with DAPI dye. The sulphenylated protein, CypD protein, and nuclei exhibited green, red, and blue fluorescence, respectively, with confocal laser-scanning microscope (Leica, Germany).</p>
</sec>
<sec id="s2-13">
<title>2.13 CypD Plasmid Transfection</title>
<p>The pcDNA3.1 vector for human CypD-WT, CypD-C82S, CypD-C104S, CypD-C157S, and CypD-C203S mutant plasmids was constructed by Sangon Biotech (Shanghai, China). When H9c2 cells grew to approximately 50&#x2013;60% confluence, the cells were treated with jetPEI TM reagent (Polyplus-transfection, France) before treatment.</p>
</sec>
<sec id="s2-14">
<title>2.14 Western Blotting Analysis</title>
<p>The protein expression of AAT1, AAT2, cleaved caspase3, caspase3, cleaved caspase9, caspase9, CypD, and His in NMCMs and H9c2 cells was detected by a standard western blotting analysis as described in the previous study (<xref ref-type="bibr" rid="B18">Huang, et&#x20;al., 2021a</xref>). Briefly, the cells were lysed using protein lysis buffer for 20&#xa0;min at 4&#xb0;C. The total protein was harvested and quantitated by the BCA method. The proteins were subjected to electrophoresis and they were subsequently transferred to nitrocellulose membranes. The protein bands were treated with primary antibodies at 4&#xb0;C overnight, respectively. Then, at room temperature, they were incubated with the corresponding horseradish peroxidase-coupled secondary antibody for 1&#xa0;h. Finally, the protein bands were incubated by using the enhanced chemiluminescent western blotting substrate kit (GE, Pittsburgh, PA, United&#x20;States) in a FluorChem M MultiFluor System (Protein Simple, San Francisco, CA, United&#x20;States).</p>
</sec>
<sec id="s2-15">
<title>2.15 Gene Ontology Cellular Component Analysis</title>
<p>A dataset containing a total of 658 SO<sub>2</sub>-mediated sulfenylated vascular smooth muscle cell (VSMC) proteins was from Huang&#x2019;s research (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2021a</xref>). The gene ontology cellular component analysis of the 658 SO<sub>2</sub>-mediated sulfenylated VSMC proteins was performed by g: Profiler (<ext-link ext-link-type="uri" xlink:href="https://biit.cs.ut.ee/gprofiler">https://biit.cs.ut.ee/gprofiler</ext-link>) (version e104_eg51_p15_3922dba). The parameters were set as follows: organism (Rattus norvegicus); statistical domain scope (only annotated genes); significance threshold (g:SCS threshold); and <italic>p</italic> values &#x3c;0.05 indicated statistical significance.</p>
</sec>
<sec id="s2-16">
<title>2.16 Statistical Analysis</title>
<p>The statistical analysis was conducted using SPSS 17.0 (IBM, USA) and Graphpad Prism 8.0 (GraphPad Software Inc., San Diego, CA, United&#x20;States). The data are expressed as mean&#x20;&#xb1; standard error. A comparison among multiple groups was performed by ANOVA followed by LSD post-doc analysis if the data were normally distributed, while followed by Dunnett T3&#x20;post-doc analysis if the data were not normally distributed. A statistical significance is set by <italic>p</italic>&#x20;&#x3c;&#x20;0.05.</p>
</sec>
</sec>
<sec id="s3">
<title>3 Results</title>
<sec id="s3-1">
<title>3.1 Endogenous SO<sub>2</sub> Controls ISO-Induced Apoptosis of Cardiomyocytes</title>
<p>ISO-stimulated NMCMs showed a marked decrease in SO<sub>2</sub> content as compared with the control group as evidenced by a significant decrease in SO<sub>2</sub>-specific green fluorescence, and an obvious decrease in AAT1 and AAT2 protein expression, and AAT activity in the ISO-stimulated NMCMs (<xref ref-type="fig" rid="F1">Figures 1A&#x2013;C</xref>), accompanied by a significant increase in cell apoptosis, as evidenced by an increase in apoptotic cells, the cleaved-caspase3/caspase3 ratio, and caspase3 activity demonstrated by colorimetric assay (<xref ref-type="fig" rid="F1">Figures 1D&#x2013;F</xref>). The supplementation of SO<sub>2</sub> donors in ISO-stimulated NMCMs restored SO<sub>2</sub> content while significantly reduced the apoptotic cells, lowered the cleaved-caspase3/caspase3 ratio, and inhibited caspase3 activity (<xref ref-type="fig" rid="F1">Figure&#x20;1</xref>). Therefore, the abovementioned data suggested that ISO stimulation downregulated the endogenous SO<sub>2</sub>/AAT pathway and promoted cardiomyocyte apoptosis; whereas adequate endogenous SO<sub>2</sub> inhibited the apoptosis of cardiomyocytes.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Endogenous SO<sub>2</sub> controls ISO-induced apoptosis of cardiomyocytes. <bold>(A)</bold> SO<sub>2</sub> production in NMCMs was tested with <italic>in situ</italic> fluorescent SO<sub>2</sub> probe (green color, magnification, &#xd7;600; scale bar: 40&#xa0;&#x3bc;m). <bold>(B)</bold> AAT1 and AAT2 expressions in NMCMs were measured by western blot. <bold>(C)</bold> AAT activity in NMCMs was detected by colorimetric assay. <bold>(D)</bold> The apoptosis of NMCMs was tested by TdT-mediated dUTP nick end labeling (TUNEL) assays (magnification, &#xd7;600; scale bar: 40&#xa0;&#x3bc;m). <bold>(E)</bold> The caspase3 cleavage in H9c2 cells was measured by using western blot method. <bold>(F)</bold> A quantitative caspase3 activity analysis was done by the colorimetric kit. Data are expressed as mean&#x20;&#xb1; SEM. &#x2217;<italic>p</italic>&#x20;&#x3c; 0.05 versus control group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 versus ISO group.</p>
</caption>
<graphic xlink:href="fcell-09-784799-g001.tif"/>
</fig>
</sec>
<sec id="s3-2">
<title>3.2 SO<sub>2</sub> Blocked ISO-Induced mPTP Opening and Subsequent Cardiomyocyte Apoptosis</title>
<p>We performed a GO-enriched cellular component (CC) reanalysis of the SO<sub>2</sub>-affected redox proteomic dataset and showed that differential proteins regulated by SO<sub>2</sub> were significantly enriched in mitochondria (<italic>p</italic>&#x20;&#x3d; 2.829 &#xd7; 10<sup>&#x2013;13</sup>) (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Furthermore, we compared the ATP fluorescence intensity in the cytoplasm, membrane, and extracellular matrix of H9c2 cells and found that ATP production was significantly reduced in H9c2 cells in the ISO group in comparison with the control group, and the supplementation with SO<sub>2</sub> significantly restored the ATP content (<xref ref-type="fig" rid="F2">Figures 2B,C</xref>), suggesting that mitochondria might be an important target for the cytoprotective effect of SO<sub>2</sub> on cardiomyocytes.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>SO<sub>2</sub> blocked ISO-induced mPTP opening and subsequent cardiomyocyte apoptosis. <bold>(A)</bold> GO-enriched cellular component (CC) reanalysis of the SO<sub>2</sub>-affected redox proteomic dataset. <bold>(B)</bold> The fluorescence intensity of cell surface and cytoplasmic ATP were investigated by the transfection of H9c2 cells with pmiATPSnFR<sup>1.1</sup> and cyto-iATPSnFR<sup>1.0</sup>, respectively (magnification, &#xd7;600; scale bar: 25&#xa0;&#x3bc;m). The ATP fluorescence intensity of extracellular matrix monitored by immunofluorescence method in H9c2 cells. <bold>(C)</bold> The mPTP opening in H9c2 cells was tested with calcein-AM. The green fluorescence quenching indicated the opening of mPTP (magnification, &#xd7;600; scale bar: 20&#xa0;&#x3bc;m). <bold>(D)</bold> The cytochrome c (cytc) leakage from the mitochondria was tested by using immunofluorescence microscopy, with red fluorescence representing cytc and green fluorescence representing mitochondria (magnification, &#xd7;600; scale bar: 50&#xa0;&#x3bc;m). <bold>(E)</bold> Caspase9 cleavage measured by western blotting. <bold>(F)</bold> A quantitative caspase9 activity analysis was done by using a commercial colorimetric kit. Data are expressed as mean&#x20;&#xb1; SEM. &#x2217;<italic>p</italic>&#x20;&#x3c; 0.05 versus control group; <sup>&#x23;</sup>
<italic>p</italic>&#x20;&#x3c; 0.05 versus ISO&#x20;group.</p>
</caption>
<graphic xlink:href="fcell-09-784799-g002.tif"/>
</fig>
<p>The mPTP opening is an important event in the development of cardiomyocyte apoptosis under a variety of cardiac pathological conditions (<xref ref-type="bibr" rid="B2">Ahmad et&#x20;al., 2019</xref>). Therefore, the present study analyzed the mitochondrial mPTP opening and downstream events. The results showed that ISO-stimulated NMCMs showed an increased mitochondrial mPTP opening, an increased cytc leakage from mitochondria, and an enhanced cleaved caspase9/caspase9 ratio and caspase9 activity in comparison with the control group; while SO<sub>2</sub> inhibited ISO-induced mPTP opening, suppressed the cytc release and reduced the ratio of cleaved caspase9/caspase9, thereby inhibiting apoptosis (<xref ref-type="fig" rid="F2">Figures 2D&#x2013;F</xref>). The results suggested that SO<sub>2</sub> significantly blocked ISO-opened mPTP, which might be involved in the mechanisms by which SO<sub>2</sub> inhibited cardiomyocyte apoptosis.</p>
</sec>
<sec id="s3-3">
<title>3.3 SO<sub>2</sub> Sulphenylated CypD and Thereby Blocked the mPTP Opening and Cardiomyocyte Apoptosis</title>
<p>CypD, a peptidyl-prolylcis-trans isomerase (PPI) present in the mitochondrial matrix, is an important redox-regulation-dependent mPTP regulator (<xref ref-type="bibr" rid="B28">Lam et&#x20;al., 2015</xref>). Therefore, we tested if CypD was a candidate target of SO<sub>2</sub> to explore the possible mechanism by which SO<sub>2</sub> blocked mitochondrial mPTP opening.</p>
<p>Firstly, there were no significant effects of SO<sub>2</sub> on the protein level of CypD either in NMCMs or in H9c2 cells as shown in <xref ref-type="fig" rid="F3">Figures 3A,B</xref> (<italic>p</italic>&#x20;&#x3e; 0.05). However, the sulphenylation of CypD in human purified CypD protein in the SO<sub>2</sub> group was markedly higher than that of the control group, which was blocked by a sulfhydryl reducing agent DTT treatment (<italic>p</italic> all&#x3c;0.05) (<xref ref-type="fig" rid="F3">Figure&#x20;3C</xref>).</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>SO<sub>2</sub> sulphenylated CypD and thereby blocked mitochondrial mPTP opening and apoptosis. CypD expressions in NMCMs and H9c2 cells were measured by western blot in <bold>(A)</bold> and <bold>(B)</bold>, respectively. <bold>(C)</bold> Sulphenylation of CypD in the purified protein with biotin switch analysis. <bold>(D)</bold> Sulphenylation of CypD in H9c2 cells with biotin switch analysis. <bold>(E)</bold> The co-localization of sulphenylated protein and CypD in H9c2 cells as detected with a DAz-2-based fluorescent probe and CypD antibody under a confocal laser-scanning microscope (magnification, &#xd7;600; scale bar: 25&#xa0;&#x3bc;m). <bold>(F)</bold> The mPTP opening in H9c2 cells was detected with calcein-AM (magnification, &#xd7;400; scale bar: 40&#xa0;&#x3bc;m). <bold>(G)</bold> The apoptosis of H9c2 cells was tested by using the TdT-mediated dUTP nick end labeling (TUNEL) method (magnification, &#xd7;600; scale bar: 25&#xa0;&#x3bc;m).</p>
</caption>
<graphic xlink:href="fcell-09-784799-g003.tif"/>
</fig>
<p>Furthermore, the quantitative analysis and <italic>in situ</italic> visualization of CypD sulphenylation in the H9c2 cells were performed. The results revealed that in comparison with the control, the sulphenylation of CypD was increased in H9c2 cells of the SO<sub>2</sub> group, which was also successfully blocked by DTT (<italic>p</italic> all&#x3c;0.05) (<xref ref-type="fig" rid="F3">Figure&#x20;3D</xref>). The multi-color confocal images showed that the co-localization of the fluorescent signals indicating CypD and sulphenylated proteins was strong in H9c2 cells of the SO<sub>2</sub> group but weak in that of the control group and SO<sub>2</sub>&#x2b;DTT group (<xref ref-type="fig" rid="F3">Figure&#x20;3E</xref>). Correspondingly, the mPTP opening and cell apoptosis were inhibited in the cells of the ISO &#x2b; SO<sub>2</sub> group in comparison with the ISO group, while DTT treatment reversed the above protective effect of SO<sub>2</sub> (<xref ref-type="fig" rid="F3">Figures&#x20;3F,H</xref>).</p>
<p>The above facts indicate that SO<sub>2</sub> can directly sulphenylate CypD protein, which might be associated with SO<sub>2</sub>-inhibited mPTP opening and cell apoptosis.</p>
</sec>
<sec id="s3-4">
<title>3.4 The CypD Cys104 Might Be a Novel Target for SO<sub>2</sub> to Inhibit mPTP Opening and Cardiomyocyte Apoptosis</title>
<p>The human purified CypD protein has four cysteine sites: Cys82, Cys104, Cys157, and Cys203 (<xref ref-type="bibr" rid="B31">Linard et&#x20;al., 2009</xref>). Homology analysis of CypD protein sequences among diverse species including human, goat, rat, mouse, pig, rabbit, chick and zebrafish showed that these four cysteine sites are all highly conserved among these different species (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). Therefore, we mutated the four cysteine sites Cys82, Cys104, Cys157, and Cys203 to serine in the CypD protein, respectively, to clarify the precise site on which SO<sub>2</sub> affected CypD and then inhibited the cardiomyocyte apoptosis. The sulphenylation site screening results showed that the sulphenylation of CypD-His could be induced by SO<sub>2</sub> treatment in the H9c2 cells transfected with CypD-WT, C82S, C157S, and C203S plasmids, except in the cells transfected with CypD C104S plasmid (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). The results suggested that the Cys104 in the CypD protein might be the sulphenylation site of&#x20;SO<sub>2</sub>.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>The CypD Cys104 might be a novel target for SO<sub>2</sub> to inhibit cardiomyocyte apoptosis. <bold>(A)</bold> Analysis of sequence homology of CypD proteins from different species. The sequences were archived from the UniProt database. <bold>(B)</bold> Sulphenylation of CypD in H9c2 cells transfected with WT or C104S, C82S, C157S, C203S-mutated CypD plasmids was measured by biotin switch analysis. <bold>(C)</bold> The mPTP opening in H9c2 cells transfected with WT or C104S-mutated CypD plasmid measured by the mPTP detection kit (magnification, &#xd7;600; scale bar: 25&#xa0;&#x3bc;m). <bold>(D)</bold> The apoptosis in H9c2 cells transfected with WT or C104S-mutated CypD plasmid measured by using the TdT-mediated dUTP nick end labeling (TUNEL) method (magnification, &#xd7;600; scale bar: 40&#xa0;&#x3bc;m).</p>
</caption>
<graphic xlink:href="fcell-09-784799-g004.tif"/>
</fig>
<p>Furthermore, the mPTP opening and the apoptosis of H9c2 cells was examined to identify if the CypD Cys104 might be the target of SO<sub>2</sub> affecting the cardiomyocyte apoptosis. The results showed that in the H9c2 cells transfected with CypD-WT plasmid, the mPTP opening in the ISO-stimulated cells was increased and the percentage of apoptotic cells was decreased by the SO<sub>2</sub> treatment, while DTT could reverse the effect of SO<sub>2</sub>. In contrast, in the H9c2 cells transfected with CypD-C104S plasmid, SO<sub>2</sub> treatment failed to affect the ISO-stimulated mPTP opening and the apoptosis (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>). The result further confirmed that SO<sub>2</sub> sulphenylated CypD cysteine at Cys104, thereby inhibiting cardiomyocyte apoptosis.</p>
</sec>
</sec>
<sec id="s4">
<title>4 Discussion</title>
<p>In the present study, we revealed, for the first time, a novel mechanism by which the endogenous SO<sub>2</sub>/AAT pathway controlled ISO-induced cardiomyocyte apoptosis, and the SO<sub>2</sub>-induced CypD sulphenylation inhibited the opening of mPTP, the downstream cytc leakage, and the activation of caspase9, thereby attenuating cardiomyocyte apoptosis. The sulphenylation of CypD cys104 is a key target for SO<sub>2</sub> to inhibit apoptosis in cardiomyocytes.</p>
<p>Previously, SO<sub>2</sub> was considered to be a toxic gas and environmental pollutant. In recent years, it is shown that the SO<sub>2</sub> can be endogenously synthesized via an enzymatic reaction catalyzed by AAT in cardiovascular tissues (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2016</xref>). The half-life time of SO<sub>2</sub> was about 5&#x2013;10&#xa0;min, demonstrated by the fact that serum SO<sub>2</sub> level was decreased by 50% about 5&#x2013;10&#xa0;min after the intravenous injection of SO<sub>2</sub> donor (<xref ref-type="bibr" rid="B14">Du et&#x20;al., 2008b</xref>). It has features of low molecular weight, continuous production, and fast diffusion and has extensive biological action independent of the membrane receptors (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2016</xref>). Endogenous SO<sub>2</sub> exerts important cardiovascular effects. For example, the reduction of endogenous SO<sub>2</sub> promotes the proliferation and migration of cardiac fibroblasts (<xref ref-type="bibr" rid="B47">Zhang et&#x20;al., 2018</xref>). SO<sub>2</sub> inhibits the VSMC proliferation by activating Cl<sup>&#x2212;</sup>/HCO<sub>3<sup>-</sup>
</sub> exchangers and acidifying cells (<xref ref-type="bibr" rid="B42">Wang Y. et&#x20;al., 2019</xref>). Endogenous SO<sub>2</sub> alleviates angiotensin II-induced myocardial hypertrophy and cardiomyocyte autophagy (<xref ref-type="bibr" rid="B6">Chen et&#x20;al., 2016</xref>). It was reported that the downregulated endogenous SO<sub>2</sub>/AAT pathway might be involved in the possible mechanisms underlying the myocardial injury. Liang <italic>et&#x20;al</italic> found that the <italic>in vivo</italic> protective effect of SO<sub>2</sub> on the myocardial injury was related to the increased myocardial antioxidant capacity (<xref ref-type="bibr" rid="B30">Liang et&#x20;al., 2011</xref>). <xref ref-type="bibr" rid="B23">Jin et&#x20;al. (2013)</xref> found that SO<sub>2</sub> attenuated myocardial injury, in association with the inhibition of myocardial apoptosis. However, the mechanisms by which SO<sub>2</sub> protects cardiomyocytes against apoptosis have not yet been elucidated.</p>
<p>In this study, we showed that ISO treatment resulted in a downregulation of the endogenous SO<sub>2</sub>/AAT2 pathway in NMCMs, as evidenced by a significantly downregulated AAT2 expression and SO<sub>2</sub> content in the ISO-stimulated cardiomyocytes. Simultaneously, cell apoptosis was evident. While the supplementation of SO<sub>2</sub> donors in ISO-stimulated NMCMs restored SO<sub>2</sub> content accompanied with a decreased cell apoptosis, cleaved-caspase3/caspase3 ratio, and caspase3 activity. These results demonstrate that endogenous SO<sub>2</sub> significantly inhibits ISO-induced apoptosis in cardiomyocytes.</p>
<p>Up to now, the possible molecular mechanisms by which endogenous SO<sub>2</sub> controls ISO-induced myocardial apoptosis have been unclear. A previous study suggested that SO<sub>2</sub> could significantly affect signaling pathways associated with cellular energy metabolism in the VSMCs (<xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2021a</xref>). A cellular component reanalysis of gene ontology enrichment on the previously reported SO<sub>2</sub>-affected protein dataset was conducted in the present study. The data showed that mitochondrion is one of the important subcellular components in which SO<sub>2</sub>-affected proteins were highly enriched. Furthermore, considering that the mitochondrion acts as a cell energy mill, the change of ATP level affected by the ISO and/or SO<sub>2</sub> treatment was investigated. As single-wavelength and genetically encoded fluorescent sensors, pmiATPSnFR1.1 and cyto-iATPSnFR1.0 were used for imaging cell surface and cytosolic ATP, respectively. The structure of pmiATPSnFR1.1 and cyto-iATPSnFR1.0 contains epsilon subunit F0F1-ATP synthase which binds to ATP. The conformation of these sensors changes and the fluorescence changes from dim to bright when bound to ATP (<xref ref-type="bibr" rid="B32">Lobas et&#x20;al., 2019</xref>). Additionally, extracellular matrix ATP binding to ecAT3.10 induces a conformational change that increases FRET between the CFP donor and YFP acceptor (<xref ref-type="bibr" rid="B8">Conley et&#x20;al., 2017</xref>). Therefore, the higher the ratio of CFP-YFPFRET to CFP, the more extracellular ATP binding, which indirectly reflects the extracellular ATP content. The results showed that ISO significantly reduced cytoplasmic ATP, cell surface ATP, and extracellular matrix ATP, while the supplementation with SO<sub>2</sub> significantly reversed the reduced ATP fluorescence intensity in the H9c2 cells of the ISO group. Taken together, the abovementioned results suggested that SO<sub>2</sub> might target the mitochondria to exert anti-apoptosis effects in cardiomyocytes.</p>
<p>The function of mitochondria is finely regulated by intrinsic factors, such as mPTP (<xref ref-type="bibr" rid="B35">Penna et&#x20;al., 2013</xref>). Therefore, we, for the first time, examined the effect of SO<sub>2</sub> on the opening of mPTP and its downstream events (cytc release, caspase9 activation, and apoptosis). The results showed that under ISO stimulation, the opening of mPTP was increased, the downstream leakage of cytc increased, the ratio of cleaved caspase9/caspase9 increased, and caspase9 activity was enhanced. While, SO<sub>2</sub> supplementation reversed the above effects of ISO on the opening of mPTP and the downstream apoptosis, suggesting that SO<sub>2</sub> might turn off mitochondrial mPTP and then inhibit cardiomyocyte apoptosis.</p>
<p>However, the possible mechanism by which SO<sub>2</sub> blocks the mitochondrial mPTP opening has not yet been known. CypD is known to be the only protein identified to regulate the mPTP opening (<xref ref-type="bibr" rid="B3">Alam et&#x20;al., 2015</xref>). CypD is a prolyl isomerase encoded by the Ppif gene and located within the mitochondrial matrix. <xref ref-type="bibr" rid="B52">Baines et&#x20;al. (2005)</xref> found that the gene deletion of the Ppif in mice protected against ischemia/reperfusion-induced cell death, whereas the mice with CypD overexpression exhibited mitochondrial swelling and spontaneous cell death. Therefore, we firstly examined whether SO<sub>2</sub> affected CypD protein expression in this study. The results revealed that SO<sub>2</sub> did not impact the expression of CypD protein in the H9c2 cells with or without ISO stimulation. As discovered in the previous studies, the post-translational modifications might impact CypD activity (<xref ref-type="bibr" rid="B34">Nguyen et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B36">Sanchez et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B20">Hurst et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B4">Amanakis et&#x20;al., 2021</xref>). For example, S-glutathionylation of CypD at the Cys203 prevented the binding between CypD and ANT, and therefore blocked mPTP (<xref ref-type="bibr" rid="B34">Nguyen et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B36">Sanchez et&#x20;al., 2011</xref>). While, due to its oxidative capacity, SO<sub>2</sub> was found to control the protein function by a sulfhydryl-dependent oxidative modification on the specific cysteinyl residue. Yao et&#x20;al. found that SO<sub>2</sub> promoted the disulfide-dependent dimerization of soluble guanylate cyclase to induce the vasodilate effect (<xref ref-type="bibr" rid="B46">Yao et&#x20;al., 2016</xref>). More importantly, SO<sub>2</sub> was reported to regulate the vascular function and structure by the sulphenylation, an important post-translational modification regulating protein function, on the target proteins such as AAT, Smad3 and NF-&#x3ba;B p65 (<xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B39">Song et&#x20;al., 2020</xref>; <xref ref-type="bibr" rid="B18">Huang et&#x20;al., 2021a</xref>). Sulphenylation refers to the oxidation of cysteine thiol groups (Cys-SH) to cysteine sulfenic acid (Cys-SOH) (<xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2017</xref>). Therefore, we explored whether CypD was able to be sulphenylated by SO<sub>2</sub>. Interestingly, the present cellular experiments and CypD purified protein assays demonstrated that SO<sub>2</sub> could sulphenylate CypD protein to inhibit mPTP opening and cardiomyocyte apoptosis.</p>
<p>To further reveal the target site by which SO<sub>2</sub> sulphenylated CypD and thereby inhibited cardiomyocyte apoptosis, we firstly performed the homology analysis of CypD protein sequences among diverse species and found that Cys82, Cys104, Cys157, and Cys203 are highly conserved. And then, the mutated CypD plasmids containing the site-directed mutant of C82S, C104S, C157S, and C203S were constructed and transfected into H9c2 cells, respectively. The screening results showed that the SO<sub>2</sub> could sulfenylate the CypD in the H9c2 cells transfected with the mutant Cys82, Cys157, and Cys203, but, interestingly, SO<sub>2</sub> failed to do so in the H9c2 cells transfected with the mutant CypD C104S. In accordance with the sulphenylation screening results, SO<sub>2</sub> failed to prevent ISO-stimulated cell apoptosis in the H9c2 cells transfected with the mutant CypD C104S. These results further confirm that SO<sub>2</sub> exerts an inhibitory effect on cardiomyocyte apoptosis by the sulphenylation of CypD at the Cys104.</p>
<p>As well known, the interaction among the different post-translational modifications on the same protein provided a fine mechanism for adjusting the protein function. For example, the persulfidation of p66Shc at Cys59 inhibited the phosphorylation at Ser36, and then blocked p66Shc activation to prevent H<sub>2</sub>O<sub>2</sub>-induced cellular senescence (<xref ref-type="bibr" rid="B44">Xie et&#x20;al., 2014</xref>). In the oleic acid-induced A549 cell inflammatory experiment, endogenous SO<sub>2</sub> sulphenylated NF-&#x3ba;B p65 in association with a decrease in the phosphorylation, nuclear translocation and DNA binding activity of NF-&#x3ba;B p65, suggesting that there might be interaction between the sulphenylation and phosphorylation of protein. While, it was reported that the phosphorylation of the Ser191 site of CypD leads to its binding to oligomycin sensitivity-conferring protein, which sensitizes mPTP opening (<xref ref-type="bibr" rid="B20">Hurst et&#x20;al., 2020</xref>). Hence, the impact of the sulphenylation of CypD on the other post-translational modifications at other sites might also contribute to the sophisticated tuning of CypD and mPTP opening.</p>
<p>The mPTP opening and the loss of mitochondrial membrane potential (MMP) are two key elements involved in the cell apoptosis (<xref ref-type="bibr" rid="B26">Kroemer and Reed, 2000</xref>). Moreover, the opening of mPTP is closely related with the decrease in the MMP (<xref ref-type="bibr" rid="B5">Bossy-Wetzel et&#x20;al., 1998</xref>; <xref ref-type="bibr" rid="B21">H&#xfc;ser and Blatter, 1999</xref>; <xref ref-type="bibr" rid="B24">Joiner et&#x20;al., 2012</xref>). Briefly, as a highly conductive and non-selective channel, the opening of mPTP increases the permeability of the inner mitochondrial membrane to ions and small solutes, and destroys the MMP and the proton gradient, resulting in the insufficient ATP production and cell apoptosis (<xref ref-type="bibr" rid="B16">Galluzzi et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B25">Kalani et&#x20;al., 2018</xref>). Zhao et&#x20;al. found that SO<sub>2</sub> restored the destroyed MMP in the alveolar macrophages treated with the serum from rats of acute lung injury and prevented the cell apoptosis (<xref ref-type="bibr" rid="B49">Zhao et&#x20;al., 2019</xref>). However, the effect of SO<sub>2</sub>-sulphenylated CypD on the MMP in the cardiomyocyte apoptosis is still unclear and merits further&#x20;study.</p>
</sec>
<sec id="s5">
<title>5 Conclusion</title>
<p>Taken together, our data highlight the important protective role of SO<sub>2</sub>-dependent site-specific CypD S-sulphenylation in inhibiting mPTP opening and reducing apoptosis in cardiomyocytes (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). Along with the in-depth studies on the biological effect of endogenous SO<sub>2</sub> and its mechanisms, the discovery of SO<sub>2</sub>-related prodrugs has become a hot topic for their potential therapeutic application (<xref ref-type="bibr" rid="B9">Day et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B41">Wang and Wang, 2018</xref>; <xref ref-type="bibr" rid="B19">Huang et&#x20;al., 2021b</xref>). A variety of SO<sub>2</sub> prodrugs based on the different releasing mechanisms, such as thiol-activated SO<sub>2</sub> prodrug, thermally activated SO<sub>2</sub> prodrug, hydrolysis-based SO<sub>2</sub> prodrug, click reaction-based SO<sub>2</sub> prodrug, and esterase-sensitive SO<sub>2</sub> prodrug, developed to meet the different research requirement or clinical application in the future. Therefore, our results would not only deepen the understanding of the mechanisms by which endogenous SO<sub>2</sub> inhibits myocardial apoptosis, but also provide new research ideas and potential therapeutic targets for myocardial protection in the future.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>A diagram showing that a novel redox mechanism by which SO<sub>2</sub> inhibits cardiomyocyte apoptosis. SO<sub>2</sub> sulphenylated mitochondrial CypD at Cys 104, which acted as a switch-off to close the mPTP opening, thereby inhibiting mitochondria-dependent cardiomyocyte apoptosis.</p>
</caption>
<graphic xlink:href="fcell-09-784799-g005.tif"/>
</fig>
</sec>
</body>
<back>
<sec id="s6">
<title>Data Availability Statement</title>
<p>All data supporting the findings of this study are available within this article or from the corresponding authors on request.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>BL, HP, BQ, LZ, MG, DB, KL, XY, JTD, and LY conducted experiments, analyzed data, and interpreted the results. BL, HP, YH, JBD, and HJ wrote the manuscript. CT, YH, JBD, and HJ designed the research, interpreted the results, and edited the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by National Natural Science Foundation of China (81970872, 81970424, 81770422, 82070445, 81921001), and Beijing Natural Science Foundation (7191012).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We thank for the scientists Mathew Tantama and Baljit Khakh that deposited the plasmids ecAT3.10, pm-iATPSnFR1.1, and cyto-iATPSnFR1.0 at Addgene.</p>
</ack>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abbate</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Narula</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Role of Apoptosis in Adverse Ventricular Remodeling</article-title>. <source>Heart Fail. Clin.</source> <volume>8</volume> (<issue>1</issue>), <fpage>79</fpage>&#x2013;<lpage>86</lpage>. <pub-id pub-id-type="doi">10.1016/j.hfc.2011.08.010</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>A. P.</given-names>
</name>
<name>
<surname>Tomar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rahmani</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Woodgett</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Cardiomyocyte-GSK-3&#x3b1; Promotes mPTP Opening and Heart Failure in Mice with Chronic Pressure Overload</article-title>. <source>J.&#x20;Mol. Cell. Cardiol.</source> <volume>130</volume>, <fpage>65</fpage>&#x2013;<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2019.03.020</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alam</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Baetz</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ovize</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Cyclophilin D and Myocardial Ischemia-Reperfusion Injury: a Fresh Perspective</article-title>. <source>J.&#x20;Mol. Cell. Cardiol.</source> <volume>78</volume>, <fpage>80</fpage>&#x2013;<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1016/j.yjmcc.2014.09.026</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amanakis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Fergusson</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>McGinty</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Molkentin</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Cysteine 202 of Cyclophilin D Is a Site of Multiple post-translational Modifications and Plays a Role in Cardioprotection</article-title>. <source>Cardiovasc. Res.</source> <volume>117</volume> (<issue>1</issue>), <fpage>212</fpage>&#x2013;<lpage>223</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvaa053</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baines</surname>
<given-names>C. P.</given-names>
</name>
<name>
<surname>Kaiser</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Purcell</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Blair</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Osinska</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hambleton</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death</article-title>. <source>Nature</source> <volume>434</volume> (<issue>7033</issue>), <fpage>658</fpage>&#x2013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1038/nature03434</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bossy-Wetzel</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Newmeyer</surname>
<given-names>D. D.</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>D. R.</given-names>
</name>
</person-group> (<year>1998</year>). <article-title>Mitochondrial Cytochrome C Release in Apoptosis Occurs Upstream of DEVD-specific Caspase Activation and Independently of Mitochondrial Transmembrane Depolarization</article-title>. <source>EMBO. J.</source> <volume>17</volume> (<issue>1</issue>), <fpage>37</fpage>&#x2013;<lpage>49</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/17.1.37</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Downregulated Endogenous Sulfur Dioxide/Aspartate Aminotransferase Pathway Is Involved in Angiotensin II-Stimulated Cardiomyocyte Autophagy and Myocardial Hypertrophy in Mice</article-title>. <source>Int. J.&#x20;Cardiol.</source> <volume>225</volume>, <fpage>392</fpage>&#x2013;<lpage>401</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijcard.2016.09.111</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Sulphur Dioxide Suppresses Inflammatory Response by Sulphenylating NF&#x2010;&#x03BA;B p65 at Cys38 in a Rat Model of Acute Lung Injury</article-title>. <source>Clin. Sci. (Lond)</source> <volume>131</volume> (<issue>21</issue>), <fpage>2655</fpage>&#x2013;<lpage>2670</lpage>. <pub-id pub-id-type="doi">10.1042/CS20170274</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conley</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Radhakrishnan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Valentino</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Tantama</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Imaging Extracellular ATP with a Genetically-Encoded, Ratiometric Fluorescent Sensor</article-title>. <source>PLoS. One.</source> <volume>12</volume> (<issue>11</issue>), <fpage>e0187481</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0187481</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Day</surname>
<given-names>J.&#x20;J.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Pacheco</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Xian</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Benzothiazole Sulfinate: a Water-Soluble and Slow-Releasing Sulfur Dioxide Donor</article-title>. <source>ACS Chem. Biol.</source> <volume>11</volume> (<issue>6</issue>), <fpage>1647</fpage>&#x2013;<lpage>1651</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.6b00106</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Deng</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Zhen</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents</article-title>. <source>Theranostics.</source> <volume>7</volume> (<issue>7</issue>), <fpage>1953</fpage>&#x2013;<lpage>1965</lpage>. <pub-id pub-id-type="doi">10.7150/thno.16478</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Abe</surname>
<given-names>J.-i.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Walsh</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Molina</surname>
<given-names>C. A.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Functional Role of Phosphodiesterase 3 in Cardiomyocyte Apoptosis</article-title>. <source>Circulation.</source> <volume>111</volume> (<issue>19</issue>), <fpage>2469</fpage>&#x2013;<lpage>2476</lpage>. <pub-id pub-id-type="doi">10.1161/01.CIR.0000165128.39715.87</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Retina-derived Endogenous Sulfur Dioxide Might Be a Novel Anti-apoptotic Factor</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>496</volume>, <fpage>955</fpage>&#x2013;<lpage>960</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2018.01.103</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.-f.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>D.-f.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.-s.</given-names>
</name>
<etal/>
</person-group> (<year>2008a</year>). <article-title>Endogenously Generated Sulfur Dioxide and its Vasorelaxant Effect in Rats</article-title>. <source>Acta. Pharmacol. Sin.</source> <volume>29</volume> (<issue>8</issue>), <fpage>923</fpage>&#x2013;<lpage>930</lpage>. <pub-id pub-id-type="doi">10.1111/j.1745-7254.2008.00845.x</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2008b</year>). <article-title>Influence of Sulfur Dioxide and its Derivatives on Rats&#x2019; Blood Pressure</article-title>. <source>J.&#x20;Appl. Clin. Pediatr.</source> <volume>23</volume> (<issue>1</issue>), <fpage>22</fpage>&#x2013;<lpage>24</lpage>. <pub-id pub-id-type="doi">10.3969/j.issn.1003-515X.2008.01.007</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elrod</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Molkentin</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Physiologic Functions of Cyclophilin D and the Mitochondrial Permeability Transition Pore</article-title>. <source>Circ. J.</source> <volume>77</volume> (<issue>5</issue>), <fpage>1111</fpage>&#x2013;<lpage>1122</lpage>. <pub-id pub-id-type="doi">10.1253/circj.cj-13-0321</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Galluzzi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Blomgren</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Mitochondrial Membrane Permeabilization in Neuronal Injury</article-title>. <source>Nat. Rev. Neurosci.</source> <volume>10</volume> (<issue>7</issue>), <fpage>481</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2665</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Endogenous Sulfur Dioxide: a New Member of Gasotransmitter Family in the Cardiovascular System</article-title>. <source>Oxid. Med. Cell. Longev.</source> <volume>2016</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1155/2016/8961951</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Endogenous SO<sub>2</sub>-dependent Smad3 Redox Modification Controls Vascular Remodeling</article-title>. <source>Redox. Biol.</source> <volume>41</volume>, <lpage>101898</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2021.101898</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Sulfur Dioxide: Endogenous Generation, Biological Effects, Detection, and Therapeutic Potential</article-title>. <source>Antioxid. Redox. Signal.</source> <pub-id pub-id-type="doi">10.1089/ars.2021.0213</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hurst</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Gonnot</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dia</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Crola Da Silva</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gomez</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sheu</surname>
<given-names>S.-S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Phosphorylation of Cyclophilin D at Serine 191 Regulates Mitochondrial Permeability Transition Pore Opening and Cell Death after Ischemia-Reperfusion</article-title>. <source>Cell. Death. Dis.</source> <volume>11</volume> (<issue>8</issue>), <fpage>661</fpage>. <pub-id pub-id-type="doi">10.1038/s41419-020-02864-5</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>H&#xfc;ser</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blatter</surname>
<given-names>L. A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Fluctuations in Mitochondrial Membrane Potential Caused by Repetitive Gating of the Permeability Transition Pore</article-title>. <source>Biochem. J.</source> <volume>343</volume>, <fpage>311</fpage>&#x2013;<lpage>317</lpage>. <pub-id pub-id-type="doi">10.1042/bj3430311</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamura</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Huynh Nhat</surname>
<given-names>K. P.</given-names>
</name>
<name>
<surname>Togawa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Saito</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Iino</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kato-Yamada</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Visualization of ATP Levels inside Single Living Cells with Fluorescence Resonance Energy Transfer-Based Genetically Encoded Indicators</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>106</volume>, <fpage>15651</fpage>&#x2013;<lpage>15656</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0904764106</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Holmberg</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>The Role of Sulfur Dioxide in the Regulation of Mitochondrion-Related Cardiomyocyte Apoptosis in Rats with Isopropylarterenol-Induced Myocardial Injury</article-title>. <source>Int. J. Mol. Sci.</source> <volume>14</volume> (<issue>5</issue>), <fpage>10465</fpage>&#x2013;<lpage>10482</lpage>. <pub-id pub-id-type="doi">10.3390/ijms140510465</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joiner</surname>
<given-names>M.-l. A.</given-names>
</name>
<name>
<surname>Koval</surname>
<given-names>O. M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>B. J.</given-names>
</name>
<name>
<surname>Allamargot</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>CaMKII Determines Mitochondrial Stress Responses in Heart</article-title>. <source>Nature.</source> <volume>491</volume> (<issue>7423</issue>), <fpage>269</fpage>&#x2013;<lpage>273</lpage>. <pub-id pub-id-type="doi">10.1038/nature11444</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalani</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S. F.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Mitochondrial Permeability Transition Pore: a Potential Drug Target for Neurodegeneration</article-title>. <source>Drug. Discov. Today.</source> <volume>23</volume> (<issue>12</issue>), <fpage>1983</fpage>&#x2013;<lpage>1989</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2018.08.001</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kroemer</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Reed</surname>
<given-names>J.&#x20;C.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Mitochondrial Control of Cell Death</article-title>. <source>Nat. Med.</source> <volume>6</volume> (<issue>5</issue>), <fpage>513</fpage>&#x2013;<lpage>519</lpage>. <pub-id pub-id-type="doi">10.1038/74994</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwong</surname>
<given-names>J.&#x20;Q.</given-names>
</name>
<name>
<surname>Molkentin</surname>
<given-names>J.&#x20;D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Physiological and Pathological Roles of the Mitochondrial Permeability Transition Pore in the Heart</article-title>. <source>Cell. Metab.</source> <volume>21</volume> (<issue>2</issue>), <fpage>206</fpage>&#x2013;<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.cmet.2014.12.001</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>W. F.</given-names>
</name>
<name>
<surname>Gardner</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Adly</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>HAX-1 Regulates Cyclophilin-D Levels and Mitochondria Permeability Transition Pore in the Heart</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source> <volume>112</volume> (<issue>47</issue>), <fpage>E6466</fpage>&#x2013;<lpage>E6475</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1508760112</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Leong</surname>
<given-names>D. P.</given-names>
</name>
<name>
<surname>Joseph</surname>
<given-names>P. G.</given-names>
</name>
<name>
<surname>McKee</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Anand</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Teo</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Schwalm</surname>
<given-names>J. D.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Reducing the Global Burden of Cardiovascular Disease, Part 2: Prevention and Treatment of Cardiovascular Disease</article-title>. <source>Circ. Res.</source> <volume>121</volume> (<issue>6</issue>), <fpage>695</fpage>&#x2013;<lpage>710</lpage>. <pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.311849</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ochs</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Endogenous Sulfur Dioxide Protects against Isoproterenol-Induced Myocardial Injury and Increases Myocardial Antioxidant Capacity in Rats</article-title>. <source>Lab. Invest.</source> <volume>91</volume> (<issue>1</issue>), <fpage>12</fpage>&#x2013;<lpage>23</lpage>. <pub-id pub-id-type="doi">10.1038/labinvest.2010.156</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Linard</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kandlbinder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Degand</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Morsomme</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Dietz</surname>
<given-names>K.-J.</given-names>
</name>
<name>
<surname>Knoops</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Redox Characterization of Human Cyclophilin D: Identification of a New Mammalian Mitochondrial Redox Sensor?</article-title> <source>Arch. Biochem. Biophys.</source> <volume>491</volume> (<issue>1-2</issue>), <fpage>39</fpage>&#x2013;<lpage>45</lpage>. <pub-id pub-id-type="doi">10.1016/j.abb.2009.09.002</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lobas</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Nagai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kronschl&#xe4;ger</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Borden</surname>
<given-names>P. M.</given-names>
</name>
<name>
<surname>Marvin</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>A Genetically Encoded Single-Wavelength Sensor for Imaging Cytosolic and Cell Surface ATP</article-title>. <source>Nat. Commun.</source> <volume>10</volume> (<issue>1</issue>), <fpage>711</fpage>. <pub-id pub-id-type="doi">10.1038/s41467-019-08441-5</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nguyen</surname>
<given-names>T. T.</given-names>
</name>
<name>
<surname>Stevens</surname>
<given-names>M. V.</given-names>
</name>
<name>
<surname>Kohr</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Steenbergen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sack</surname>
<given-names>M. N.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Cysteine 203 of Cyclophilin D Is Critical for Cyclophilin D Activation of the Mitochondrial Permeability Transition Pore</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>286</volume> (<issue>46</issue>), <fpage>40184</fpage>&#x2013;<lpage>40192</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M111.243469</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Penna</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Perrelli</surname>
<given-names>M.-G.</given-names>
</name>
<name>
<surname>Pagliaro</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Mitochondrial Pathways, Permeability Transition Pore, and Redox Signaling in Cardioprotection: Therapeutic Implications</article-title>. <source>Antioxid. Redox. Signal.</source> <volume>18</volume> (<issue>5</issue>), <fpage>556</fpage>&#x2013;<lpage>599</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2011.4459</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>S&#xe1;nchez</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Fern&#xe1;ndez</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Montecinos</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Domenech</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Donoso</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Preconditioning Tachycardia Decreases the Activity of the Mitochondrial Permeability Transition Pore in the Dog Heart</article-title>. <source>Biochem. Biophysical. Res. Commun.</source> <volume>410</volume> (<issue>4</issue>), <fpage>916</fpage>&#x2013;<lpage>921</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2011.06.095</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Singh</surname>
<given-names>K. P.</given-names>
</name>
<name>
<surname>Jaffe</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>B. T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>The Clinical Impact of Circulating Caspase3 P17 Level: a Potential New Biomarker for Myocardial Injury and Cardiovascular Disease</article-title>. <source>Future. Cardiol.</source> <volume>7</volume> (<issue>4</issue>), <fpage>443</fpage>&#x2013;<lpage>445</lpage>. <pub-id pub-id-type="doi">10.2217/fca.11.29</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Geng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Tu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Sirtuin 3-dependent Mitochondrial Redox Homeostasis Protects against AGEs-Induced Intervertebral Disc Degeneration</article-title>. <source>Redox. Biol.</source> <volume>19</volume>, <fpage>339</fpage>&#x2013;<lpage>353</lpage>. <pub-id pub-id-type="doi">10.1016/j.redox.2018.09.006</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>Z.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Negative Auto-Regulation of Sulfur Dioxide Generation in Vascular Endothelial Cells: AAT1&#x20;S-Sulfenylation</article-title>. <source>Biochem. Biophysical. Res. Commun.</source> <volume>525</volume>, <fpage>231</fpage>&#x2013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2020.02.040</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ding</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ao</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Parkin Regulates Programmed Necrosis and Myocardial Ischemia/reperfusion Injury by Targeting Cyclophilin-D</article-title>. <source>Antioxid. Redox. Signal.</source> <volume>31</volume> (<issue>16</issue>), <fpage>1177</fpage>&#x2013;<lpage>1193</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2019.7734</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>SO<sub>2</sub> Donors and Prodrugs, and Their Possible Applications: A Review</article-title>. <source>Front. Chem.</source> <volume>6</volume>, <fpage>559</fpage>. <pub-id pub-id-type="doi">10.3389/fchem.2018.00559</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>W.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>L-cystathionine Protects against Homocysteine-Induced Mitochondria-dependent Apoptosis of Vascular Endothelial Cells</article-title>. <source>Oxid. Med. Cell. Long.</source> <volume>2019</volume>, <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1155/2019/1253289</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Sulfur Dioxide Activates Cl<sup>-</sup>/HCO<sub>3<sup>-</sup>
</sub> Exchanger via Sulphenylating AE2 to Reduce Intracellular pH in Vascular Smooth Muscle Cells</article-title>. <source>Front. Pharmacol.</source> <volume>10</volume>, <fpage>313</fpage>. <pub-id pub-id-type="doi">10.3389/fphar.2019.00313</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xie</surname>
<given-names>Z. Z.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hua</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Sulfhydration of p66Shc at Cysteine59 Mediates the Antioxidant Effect of Hydrogen Sulfide</article-title>. <source>Antioxid. Redox. Signal.</source> <volume>21</volume> (<issue>18</issue>), <fpage>2531</fpage>&#x2013;<lpage>2542</lpage>. <pub-id pub-id-type="doi">10.1089/ars.2013.5604</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>K. K.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>A Novel Coumarin-Based Water-Soluble Fluorescent Probe for Endogenously Generated SO<sub>2</sub> in Living Cells</article-title>. <source>Sci. China. Chem.</source> <volume>60</volume> (<issue>6</issue>), <fpage>793</fpage>&#x2013;<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1007/s11426-016-0411-7</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>The Vasodilatory Effect of Sulfur Dioxide via sGC/cGMP/PKG Pathway in Association with Sulfhydryl-dependent Dimerization</article-title>. <source>Am. J.&#x20;Physiol. Regul. Integr. Comp. Physiol.</source> <volume>310</volume> (<issue>11</issue>), <fpage>R1073</fpage>&#x2013;<lpage>R1080</lpage>. <pub-id pub-id-type="doi">10.1152/ajpregu.00101.2015</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J. B.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H. F.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y. Q.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Inhibitory Effects of Sulfur Dioxide on Rat Myocardial Fibroblast Proliferation and Migration</article-title>. <source>Chin. Med. J.&#x20;(Engl).</source> <volume>131</volume> (<issue>14</issue>), <fpage>1715</fpage>&#x2013;<lpage>1723</lpage>. <pub-id pub-id-type="doi">10.4103/0366-6999.235875</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>S. Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Endogenous Sulfur Dioxide Is a Novel Inhibitor of Hypoxia-Induced Mast Cell Degranulation</article-title>. <source>J.&#x20;Adv. Res.</source> <volume>29</volume>, <fpage>55</fpage>&#x2013;<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2020.08.017</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Y. R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>W. R.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.&#x20;L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Effects of Sulfur Dioxide on Alveolar Macrophage Apoptosis in Acute Lung Injury Induced by Limb Ischemia/reperfusion in Rats</article-title>. <source>Beijing. Da. Xue. Xue. Bao. Yi. Xue. Ban.</source> <volume>51</volume> (<issue>2</issue>), <fpage>239</fpage>&#x2013;<lpage>244</lpage>. <pub-id pub-id-type="doi">10.19723/j.issn.1671-167X.2019.02.007</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kreuzer</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kumsta</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kamer</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Cedillo</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Mitochondrial Permeability Uncouples Elevated Autophagy and Lifespan Extension</article-title>. <source>Cell.</source> <volume>177</volume> (<issue>2</issue>), <fpage>299</fpage>&#x2013;<lpage>314</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2019.02.013</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Sulfur Dioxide: an Endogenous Protector against Myocardial Injury</article-title>. <source>J.&#x20;Cardiovasc. Pharmacol.</source> <volume>76</volume> (<issue>4</issue>), <fpage>389</fpage>&#x2013;<lpage>396</lpage>. <pub-id pub-id-type="doi">10.1097/FJC.0000000000000882</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>